FolioLanternBeta
MDGLMadrigal Pharmaceuticals, Inc.

Daniel Brennan

Director at Madrigal Pharmaceuticals, Inc., as of Jun 18, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
1.4K
shares held after the latest filing, Madrigal Pharmaceuticals, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
3
companies filed for

Last filing: Jun 18, 2026.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Madrigal Pharmaceuticals, Inc. (MDGL)DirectorAug 5, 2025Jun 18, 2026
Waters Corporation (WAT)DirectorNov 28, 2022Feb 27, 2026
Boston Scientific (BSX)Former EVP and CFOJan 9, 2014Feb 19, 2025

Also a director at

Waters Corporation (WAT)

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.